BARCLAYS PLC

Form 8.3 - Aon plc - Amendment

Form 8.3 - Aon plc - Amendment

BARCLAYS PLC

 

Ap19

FORM 8.3 - Amendment to Purchase and Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 29 May 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

249,353

0.11%

920,764

0.40%

 

 

(2)

Derivatives (other than options):

 

 

481,466

0.21%

29,700

0.01%

 

 

(3)

Options and agreements to

 

 

purchase/sell:

2,600

0.00%

4,500

0.00%

 

 

TOTAL:

 

 

733,419

0.32%

954,964

0.41%

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

1

197.2700 USD
Purchase

18

197.2900 USD
Purchase

100

196.4000 USD
Purchase

100

196.2000 USD
Purchase

100

196.6100 USD
Purchase

100

196.7100 USD
Purchase

100

196.6200 USD
Purchase

107

198.0400 USD
Purchase

200

196.4050 USD
Purchase

206

197.4710 USD
Purchase

496

197.1370 USD
Purchase

711

197.0027 USD
Purchase

788

196.9660 USD
Purchase

2,898

196.5539 USD
Purchase

2,965

196.7814 USD
Purchase

4,185

197.5348 USD
Purchase

5,800

197.4748 USD
Purchase

8,622

196.4731 USD
Purchase

9,610

196.9311 USD
Purchase

14,310

196.9130 USD
Purchase

16,656

196.6398 USD
Purchase

17,609

197.2740 USD
Purchase

17,879

196.8879 USD
Purchase

18,066

197.0461 USD
Purchase

51,264

196.9434 USD
Purchase

105,669

196.9500 USD
Sale

12

197.3700 USD
Sale

19

197.2889 USD
Sale

25

197.1100 USD
Sale

30

197.0300 USD
Sale

36

197.2400 USD
Sale

55

196.9627 USD
Sale

100

196.2000 USD
Sale

100

197.1000 USD
Sale

100

197.3600 USD
Sale

100

197.5500 USD
Sale

100

197.5600 USD
Sale

100

197.9150 USD
Sale

100

198.5100 USD
Sale

200

196.7050 USD
Sale

200

197.2050 USD
Sale

211

196.6194 USD
Sale

300

197.4366 USD
Sale

300

197.7166 USD
Sale

300

197.3133 USD
Sale

300

197.2566 USD
Sale

300

197.2513 USD
Sale

320

197.3562 USD
Sale

400

196.7875 USD
Sale

500

197.2210 USD
Sale

587

197.2000 USD
Sale

599

197.2835 USD
Sale

638

196.7575 USD
Sale

665

197.2246 USD
Sale

700

196.8546 USD
Sale

778

196.8583 USD
Sale

788

196.9660 USD
Sale

900

196.7000 USD
Sale

916

196.8762 USD
Sale

1,000

196.7090 USD
Sale

1,175

197.0962 USD
Sale

1,300

196.9736 USD
Sale

1,339

196.9677 USD
Sale

1,383

197.0541 USD
Sale

1,500

196.7346 USD
Sale

3,023

197.3232 USD
Sale

3,214

196.9109 USD
Sale

3,272

197.1762 USD
Sale

3,313

197.5929 USD
Sale

4,200

196.9857 USD
Sale

5,032

197.4985 USD
Sale

5,067

196.9394 USD
Sale

6,407

197.1684 USD
Sale

7,722

196.4352 USD
Sale

8,610

196.9087 USD
Sale

13,010

196.9070 USD
Sale

15,139

196.9747 USD
Sale

75,808

196.9113 USD
Sale

108,916

196.9500 USD

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction

Number of relevant securities

Price per

 

unit
SWAP Long

7,722

196.4152 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

2 Jun 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or

Number of

Exercise

Type

Expiry

purchased

relevant securities

price

date

to which the option

 

 

or derivative

 

 

relates

 

 

Call Options Purchased

1,100

260.0000

American

Jul 17, 2020

Call Options Purchased

1,500

240.0000

American

Jul 17, 2020

Call Options Written

-4,500

220.0000

American

Jul 17, 2020

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.